Research Techniques Made Simple: Delivery of the CRISPR/Cas9 Components into Epidermal Cells

J Invest Dermatol. 2021 Jun;141(6):1375-1381.e1. doi: 10.1016/j.jid.2021.01.008.

Abstract

CRISPR/Cas9 technology is a powerful tool used to alter the genetic landscape of various hosts. This has been exemplified by its success in the transgenic animal world where it has been utilized to develop novel mouse lines modeling numerous disease states. The technology has helped to develop both in vitro and in vivo systems that simulate diseases within the fields of epithelial biology, skin cancer biology, dermatology, and beyond. Importantly, the delivery of the single-guide RNA/Cas9 editing complex to the host cell is key for its success. In this paper, we discuss the various methods that have been utilized as delivery techniques for CRISPR/Cas9 components, the benefits and pitfalls of each, and how successful they have been at genetically modifying epidermal cells. In addition, we acknowledge recent advances in the field of dermatology that have harnessed these methods to better understand epidermal biology, identify potential therapeutic targets, or serve as novel methods to treat disease states.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Genetically Modified
  • CRISPR-Cas Systems / genetics*
  • Disease Models, Animal
  • Gene Transfer Techniques*
  • Genetic Vectors
  • Humans
  • Keratinocytes / pathology
  • Mutation
  • Primary Cell Culture
  • RNA, Guide, CRISPR-Cas Systems / genetics
  • Skin Diseases / genetics*
  • Skin Diseases / pathology

Substances

  • RNA, Guide, CRISPR-Cas Systems